top of page
© 2021-2024 Marine Pharmacology
Approved Marine Drugs
Last Update: October 10, 2024
NOTE: Clinical trial numbers were updated and may include Phase 3, as well as Phase 2 and Phase 1 if ongoing.
Withdrawn
​​
ABBREVIATIONS:
-
ADC: Antibody Drug Conjugate;
-
Ara-A: 9-β-D-arabinofuranosyladenine
-
Ara-C: Cytosine Arabinoside
-
BCMA: B-cell Maturation Antigen
-
CD: Cluster of Differentiation;
-
c-Met: Tyrosine-Protein Kinase Met
-
DMXBA: 3-(2,4-Dimethoxybenzylidene)-Anabaseine
-
EGFR: Epidermal Growth Factor Receptor;
-
ENPP3: Ectonucleotide Pyrophosphatase/Phosphodiesterase Family Member 3
-
FDA: Food and Drug Administration;
-
GPNMB: Glycoprotein nonmetastatic B;
-
LIV-1: Zinc transporter SLC39A6;
-
LRRC15: Leucine rich repeat containing 15
-
MMAE: Monomethylauristatin E;
-
MMAF: Monomethylauristatin F;
-
NaPi2b: Sodium-Dependent Phosphate Transport Protein 2b;
-
PSMA: Prostate-Specific Membrane Antigen;
-
TIM-1: T-cell Immunoglobulin domain 1
© 2021-2024 Marine Pharmacology
bottom of page